Seroatlas · Human Serome Atlas

U2AF2

Splicing factor U2AF 65 kDa subunit

Also known as: U2AF2_HUMAN, U2AF65

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
P26368
Gene
U2AF2
Ensembl
ENSG00000063244
Chromosome
19
Canonical length
475 aa
Protein class
Plasma proteins, Predicted intracellular proteins
Subcellular location
Nucleoplasm,Nuclear speckles

OverviewNCBI Gene

U2 auxiliary factor (U2AF), comprised of a large and a small subunit, is a non-snRNP protein required for the binding of U2 snRNP to the pre-mRNA branch site. This gene encodes the U2AF large subunit which contains a sequence-specific RNA-binding region with 3 RNA recognition motifs and an Arg/Ser-rich domain necessary for splicing. The large subunit binds to the polypyrimidine tract of introns early during spliceosome assembly. Multiple transcript variants have been detected for this gene, but the full-length natures of only two have been determined to date. [provided by RefSeq, Jul 2008]

Canonical amino-acid sequenceUniProt

475 residues, UniProt reviewed canonical sequence.

>P26368|U2AF2
     1  MSDFDEFERQ LNENKQERDK ENRHRKRSHS RSRSRDRKRR SRSRDRRNRD QRSASRDRRR
    61  RSKPLTRGAK EEHGGLIRSP RHEKKKKVRK YWDVPPPGFE HITPMQYKAM QAAGQIPATA
   121  LLPTMTPDGL AVTPTPVPVV GSQMTRQARR LYVGNIPFGI TEEAMMDFFN AQMRLGGLTQ
   181  APGNPVLAVQ INQDKNFAFL EFRSVDETTQ AMAFDGIIFQ GQSLKIRRPH DYQPLPGMSE
   241  NPSVYVPGVV STVVPDSAHK LFIGGLPNYL NDDQVKELLT SFGPLKAFNL VKDSATGLSK
   301  GYAFCEYVDI NVTDQAIAGL NGMQLGDKKL LVQRASVGAK NATLVSPPST INQTPVTLQV
   361  PGLMSSQVQM GGHPTEVLCL MNMVLPEELL DDEEYEEIVE DVRDECSKYG LVKSIEIPRP
   421  VDGVEVPGCG KIFVEFTSVF DCQKAMQGLT GRKFANRVVV TKYCDPDSYH RRDFW

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against U2AF2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Intracellular
Secreted
No
Transmembrane segments
0
Mean surface accessibility (rSASA)
0.41
Highest tissue expression
96 nTPM

Expression across tissuesHPA

Tissue

  • bone marrow: 96 nTPM
  • thymus: 86 nTPM
  • spleen: 73 nTPM
  • lymph node: 72 nTPM
  • pituitary gland: 70 nTPM
  • appendix: 68 nTPM

Single-cell type

  • syncytiotrophoblasts: 83 nCPM
  • oocytes: 78 nCPM
  • migrating cytotrophoblasts: 76 nCPM
  • extravillous trophoblasts: 73 nCPM
  • cytotrophoblasts: 68 nCPM
  • adrenal cortex cells: 64 nCPM

Immune cell

  • neutrophil: 2.1 nTPM
  • plasmacytoid DC: 1.7 nTPM
  • intermediate monocyte: 1.4 nTPM
  • gdT-cell: 1.2 nTPM
  • non-classical monocyte: 1.2 nTPM
  • classical monocyte: 1.1 nTPM

Brain region

  • white matter: 66 nTPM
  • medulla oblongata: 64 nTPM
  • choroid plexus: 61 nTPM
  • cerebellum: 60 nTPM
  • thalamus: 57 nTPM
  • cerebral cortex: 57 nTPM

DiseaseUniProt · ClinVar · IEDB · PubMed

Four sources answering four different questions about U2AF2.

Disease | AllUniProt

Conditions U2AF2 is implicated in, by any mechanism.

Disease | GeneticClinVar

13 pathogenic / likely-pathogenic of 96 ClinVar records.

Conditions with pathogenic or likely-pathogenic variants.

Disease | ImmuneIEDB

Conditions an epitope on U2AF2 was assayed in.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
0.13
gnomAD pLI
1
gnomAD missense Z
4.71
DepMap mean gene effect
-1.43
DepMap dependency class
pan

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of U2AF2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads U2AF2 as an antibody target. Whether an autoantibody or antibody against U2AF2 could matter depends on whether native U2AF2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

U2AF2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.

Annotation status

The present source text does not explicitly label U2AF2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/U2AF2. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...